Company intelligence / Profile preview

NewLeaf Symbiotics

St. Louis, Missouri, USAnewleafsym.com ↗
Ownership
Private
Employees
~61
Development stage
Commercial
01

Overview

NewLeaf Symbiotics has commercialized a suite of agricultural biological products based on proprietary pink-pigmented facultative methylotrophs (PPFMs). Their EPA-approved TS201 bioinsecticide repels corn rootworm with a novel mode of action and has shown consistent yield advantages. The company also markets biostimulants that improve crop yields across multiple crops. In field trials and early commercialization phases, their technologies have demonstrated reliable performance advantages over standard practices. Ongoing R&D includes new biocontrol agents and solutions targeting nitrogen use efficiency and methane mitigation.

Therapeutic areas
OtherInfectious Diseases
Modalities
Microbial therapyMicrobial inoculantBiostimulantBioinsecticide
Industry
Agriculture & AgTech
02

Drug pipeline

4 assets

Terrasym 401

Commercial
Indications
Soybean yield improvement

3 more assets in the full pipeline.

Request access →
03

Partnerships

Leaps by BayerS2G VenturesOtter Capital Partners LPGullspång Refood

Beyond the preview

Go deeper on NewLeaf Symbiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NewLeaf Symbiotics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call